Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,339 shares of Class A Common Stock on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 1, 2024, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., sold 2,339 shares of Class A Common Stock.
• The sale was executed at a price of $18.5 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted by Boughton on September 10, 2023.
• Following the transaction, Boughton directly owns 174,613 shares of Hims & Hers Health, Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction was pre-planned under a 10b5-1 trading plan. It doesn't necessarily indicate a positive or negative outlook on the company's future.

Industry Context

Insider sales are common and often pre-planned using 10b5-1 trading plans to avoid accusations of trading on non-public information. The market typically analyzes these sales in the context of overall company performance and insider sentiment.

Stakeholder Impact

• The sale could have a minor impact on shareholder sentiment, depending on how the market interprets the insider selling activity.

Key Dates